Access webinars and podcasts that discuss the power of genomic-based diagnostics for advancing cancer care in dogs.
Dr. Esther Chon appeared on The Margin VSSO Podcast with Dr. Gerry Post from Fidocure. Their discussion explored the profound impact of genomics and personalized medicine on veterinary oncology. (51 minutes)
Dr. Esther Chon, author of “Genomic tumor analysis provides clinical guidance for the management of diagnostically challenging cancers in dogs in: Journal of the American Veterinary Medical Association – Ahead of print (avma.org),” discusses how an evidence-driven genomic assay provided diagnostic guidance, prognostic support, and therapeutic options for patients with an unclear cancer diagnosis. Hosted by Associate Editor Dr. Sarah Wright and Editor-in-Chief Dr. Lisa Fortier. (20 minutes)
Our Head of Clinical Curation, Dr. Guannan Wang, was featured on the Conversations with COSMIC podcast. She explains how our curation team uses COSMIC to develop our canine cancer genomic database — the future of precision oncology in animal medicine! (39 minutes)
This webinar informs veterinary practitioners about the clinical applications of cancer genomics in the management of canine lymphoma and mast cell tumors. The presentation begins with an overview of how to incorporate genomics into daily clinical practice, followed by a review of each cancer type and how genomic findings can expand treatment options for the management of those types. The discussion concludes with a deep dive into trametinib, the third in our series of targeted therapies. This free program has been approved for 1 hour of continuing education credit in jurisdictions that recognize RACE approval. (67 minutes)
In this webinar, explore the clinical applications of cancer genomics in canine osteosarcoma. Dr. Esther Chon will provide an overview of osteosarcoma, how to incorporate genomics into daily clinical practice, and how genomic findings can expand treatment options for osteosarcoma management. Olaparib, the second drug in our series of targeted therapies, will also be discussed. This free program has been approved for 1 hour of continuing education credit in jurisdictions that recognize RACE approval. (65 minutes)
In this webinar, explore the clinical application of cancer genomics in canine melanoma. The presentation will begin with an overview of frequently identified mutations in canine melanoma, followed by a focus on the common therapeutic biomarkers associated with targeted therapies and a deep dive into palbociclib. This free program has been approved for 1 hour of continuing education credit in jurisdictions that recognize RACE approval. (60 minutes)
Watch as Dr. David Haworth and Dr. William Hendricks discuss precision medicine and its clinical applicability to veterinary oncology. This free program has been approved for 1 hour of continuing education credit in jurisdictions that recognize RACE approval. (50 minutes)
When we can identify specific cancer mutations, we can give them a name and a treatment plan, and help make them less scary. Dr. David Haworth of Vidium Animal Health talks about cancer genomics and molecular diagnostics. (26 minutes)
Hear genomics and veterinary experts William Hendricks, Esther Chon, Derick Whitley, and David Haworth discuss the diagnostic, therapeutic, and prognostic utility of genomics in veterinary oncology and explore case examples in which genomics can aid in the diagnosis and therapeutic approach for treatment of canine cancer. This program has been approved for 1 hour of continuing education credit in jurisdictions that recognize RACE approval. (60 minutes)
This informative discussion, which provides 1 hour of CE credit, explores the science behind cancer genomics and precision medicine, as well as the potential for using genomic diagnostics to guide the clinical management of pets with cancer. (21 minutes)
Veterinarian and Vidium president Dr. David Haworth discusses how Vidium can help inform veterinarians and pet parents about which mutations are causing their pet’s cancer. (14 minutes)
Listen in to learn more about SearchLight DNA and how it can be used alongside histopathology to determine the best treatment plan for your dog, explained by medical oncologist, Dr. Esther Chon. (43 minutes)
Cancer is the number one worry of pet parents, and it’s no wonder. More than half of all dogs older than 10 will be diagnosed with cancer. Cancer is hard to treat in many dogs, and is often diagnosed when it’s too late to treat. Americans spent more than $120 billion on their pets just last year. One TGen subsidiary is putting its science to work for pet parents, so that cancer in dogs is diagnosed before it’s too late. Vidium Animal Health is a wholly owned subsidiary of TGen and it works to diagnose and treat canine cancers. Joining TGen Talks is Vidium president Dr. David Haworth.